Rifampicin inhibits apoptosis in rotenone-induced differentiated PC12 cells by ameliorating mitochondrial oxidative stress

被引:12
作者
Chen, Shiwen [1 ]
Sun, Yuanlin [1 ]
Zeng, Zhifeng [1 ]
Tao, Enxiang [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 2, Dept Neurol, Guangzhou 510120, Guangdong, Peoples R China
关键词
rifampicin; rotenone; PC12; cells; mitochondrial dysfunction; oxidative stress; apoptosis; neural regeneration; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; NEUROTOXICITY; METABOLISM; BRAIN; ASSAY;
D O I
10.3969/j.issn.1673-5374.2010.04.002
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
BACKGROUND: Previous studies have shown that rifampicin exhibits neuroprotective effects, but the precise mechanisms remain unclear. Rifampicin is thought to exert the neuroprotective effect as a hydroxyl free radical scavenger. OBJECTIVE: To investigate the protective effects of rifampicin pretreatment on rotenone-induced mitochondrial oxidative stress in differentiated PC12 cells. DESIGN, TIME AND SETTING: A repeated measure, cell-based study was performed at the Department of Neurology, Second Affiliated Hospital, Sun Yat-sen University, China between December 2007 and November 2008. MATERIALS: PC12 cells were a kind gift from the Physiology Laboratory of Zhongshan Medical School, Sun Yat-sen University, China. Rotenone and rifampicin were purchased from Sigma, USA. METHODS: PC12 cells were differentiated by culturing with 100 ng/mL 7S nerve growth factor for 9 days in Dulbecco's modified Eagle's medium/Nutrient Mix F12 (DMEM/F12) supplemented with 10% fetal bovine serum. The cells were assigned to six groups according to various treatment conditions: control, cultured with normal media; rifampicin group, treated with 300 mu mol/L rotenone for 26 hours; rotenone group, treated with 2.5 mu mol/L rotenone for 24 hours; rifampicin pretreatment groups, pretreated with 100, 200, and 300 mu mol/L rifampicin for 2 hours, respectively, followed by 2.5 mu mol/L rotenone for 24 hours. MAIN OUTCOME MEASURES: Mitochondrial membrane potential was measured by fluorescence microscopy and flow cytometry, respectively, using rhodamine 123 staining. Intracellular reactive oxygen species formation was analyzed by flow cytometry using 2', 7'-dichlorofluorescin-diacetate staining, and intracellular reduced glutathione was measured with a microplate reader. Cell viability was determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay. Cell apoptosis was detected by Hoechst 33342 staining and flow cytometry. RESULTS: Increased apoptosis in rotenone-induced, differentiated, PC12 cells was accompanied by the loss of mitochondrial transmembrane potential, the formation of reactive oxygen species, and reduced glutathione depletion (P < 0.01). Rotenone-induced mitochondrial dysfunction was blocked in a dose-dependent manner by rifampicin (P < 0.05 or P < 0.01). CONCLUSION: Pretreatment of differentiated PC12 cells with rifampicin blocked rotenone-induced apoptosis by ameliorating mitochondrial dysfunction and oxidative stress.
引用
收藏
页码:251 / 256
页数:6
相关论文
共 32 条
[1]
Parkinson's disease - Redox mechanisms [J].
Adams, JD ;
Chang, ML ;
Klaidman, L .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (07) :809-814
[2]
Babic T, 2008, COLLEGIUM ANTROPOL, V32, P1275
[3]
MICROTITER PLATE ASSAY FOR THE MEASUREMENT OF GLUTATHIONE AND GLUTATHIONE DISULFIDE IN LARGE NUMBERS OF BIOLOGICAL SAMPLES [J].
BAKER, MA ;
CERNIGLIA, GJ ;
ZAMAN, A .
ANALYTICAL BIOCHEMISTRY, 1990, 190 (02) :360-365
[4]
DOES IMPAIRMENT OF ENERGY-METABOLISM RESULT IN EXCITOTOXIC NEURONAL DEATH IN NEURODEGENERATIVE ILLNESSES [J].
BEAL, MF .
ANNALS OF NEUROLOGY, 1992, 31 (02) :119-130
[5]
The role of α-synuclein in neurodegenerative diseases [J].
Bennett, MC .
PHARMACOLOGY & THERAPEUTICS, 2005, 105 (03) :311-331
[6]
Rifampin reduces production of reactive oxygen species of cerebrospinal fluid phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis [J].
Böttcher, T ;
Gerber, J ;
Wellmer, A ;
Smirnov, AV ;
Fakhrjanali, F ;
Mix, E ;
Pilz, J ;
Zettl, UK ;
Nau, R .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (06) :2095-2098
[7]
New hope for mechanism-based treatment of Parkinson's disease [J].
Bradbury, J .
DRUG DISCOVERY TODAY, 2005, 10 (02) :80-81
[8]
CHUI DH, 1994, AM J PATHOL, V145, P771
[9]
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition [J].
Costa, Cinzia ;
Belcastro, Vincenzo ;
Tozzi, Alessandro ;
Di Filippo, Massimiliano ;
Tantucci, Michela ;
Siliquini, Sabrina ;
Autuori, Alessia ;
Picconi, Barbara ;
Spillantini, Maria Grazia ;
Fedele, Ernesto ;
Pittaluga, Anna ;
Raiteri, Maurizio ;
Calabresi, Paolo .
JOURNAL OF NEUROSCIENCE, 2008, 28 (32) :8040-8052
[10]
Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215